USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-29 обновлены отчеты компании GALT: 2023 ∙ 2022
  1. Главная
  2. Котировки акций
  3. Galectin Therapeutics
  4. Мультипликаторы
Galectin Therapeutics logo
Galectin Therapeutics GALT
$ 3.37 0.0%
mail-toСообщить о неточности

Galectin Therapeutics Мультипликаторы 2011-2024 | GALT

Мультипликаторы по годам Galectin Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -3.5 -3.0 -3.6 -4.8 -10.4 -14.0 -10.4 -1.4 -1.7 -4.5 -18.0 -4.1 -5.3

P/S

 - - - - - - - - - - - - -

EPS

 -0.7 -0.7 -0.5 -0.4 -0.4 -0.4 -0.5 -0.8 -0.9 -0.8 -1.3 -0.7 -1.1

EV (Enterprise Value)

 207 млн 151 млн 109 млн 90 млн 93.3 млн 188 млн 169 млн 17.6 млн 9.52 млн 42.9 млн 209 млн 32.4 млн 60.6 млн

EBITDA per Share

 - - -0.52 -0.411 -0.257 -0.344 -0.457 -0.735 -0.832 -0.706 -0.717 -0.654 -0.868

EV/EBITDA

 -1.9 -3.6 -6.7 -13.7 -10.2 -0.6 -0.4 -2.7 -17.1 -3.1 -5.0

PEG

 0.24 13.99 0.87 3.94 -0.62 -0.29 -0.1 0.13 -0.11 0.22 -0.13 0.3

P/B

 -2.4 -3.6 41.8 4.6 3.0 28.1 141.4 2.4 1.4 2.5 26.4 5.1 -27.4

P/CF

 -4.4 -3.7 -4.5 -5.4 -12.7 -19.1 -10.6 -1.8 -2.0 -5.7 -29.0 -5.3 -10.3

ROE %

 66.27 114.33 -3418.48 -96.99 -29.16 -201.51 -1360.85 -178.41 -79.95 -56.44 -146.93 -122.21 513.65

ROA %

 -145.62 -182.18 -72.98 -79.27 -27.43 -154.34 -390.17 -135.71 -75.84 -53.20 -112.83 -101.19 -165.08

ROCE %

 61.44 113.08 -3379.51 -96.96 -29.44 -197.19 -1361.86 -178.78 -80.16 -55.16 -147.13 -124.94 -236.73

Current Ratio

 0.3 0.4 1.1 5.5 17.1 4.2 1.3 4.2 19.4 17.4 4.3 5.8 2.9

DSO

 - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - -

Операционный цикл

 - - - - - - - - - - - - -

Финансовый цикл

 - - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Galectin Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.24 -0.15 -0.19 - -0.14 -0.16 -0.17 - -0.14 -0.15 -0.11 - -0.1 -0.11 -0.06 - -0.05 -0.06 -0.2 - 0.07 0.11 0.12 - -0.13 -0.14 -0.15 - -0.16 -0.2 -0.24 -0.19 -0.26 -0.21 -0.22 -0.17 -0.17 -0.17 -0.27 -0.14 -0.22 -0.72 -0.22 - -0.19 -0.19 -0.17 - -0.19 -0.34 -0.24

EBITDA per Share

 - - - - -0.14 -0.16 -0.17 - -0.14 -0.14 -0.11 - -0.1 -0.11 -0.06 - -0.05 -0.06 -0.05 - -0.07 -0.1 -0.11 - -0.13 -0.13 -0.15 - -0.15 -0.19 -0.24 - -0.25 -0.2 -0.21 - -0.16 -0.15 -0.24 - -0.21 -0.16 -0.2 - -0.18 -0.17 -0.15 - -0.16 -0.26 -0.16

ROE %

 98.79 114.69 154.18 217.93 104.72 -44.22 -155.84 -206.48 -232.93 -146.17 -118.49 -69.48 -75.83 -55.73 -35.35 -18.59 -71.77 -118.60 -185.97 -209.66 622.04 1506.91 2431.68 2613.77 2569.80 1694.12 789.93 -163.67 -189.56 -178.22 -150.33 -111.01 -102.73 -86.69 -77.13 -74.49 -245.88 -468.44 -624.04 -816.21 -858.03 -849.68 -906.23 -626.52 -531.09 -204.84 170.64 355.15 95.44 147.15 112.56

ROA %

 -197.42 -198.36 -190.11 -114.67 -137.07 -111.48 -99.64 -75.37 -95.45 -93.13 -88.49 -52.75 -58.49 -44.16 -29.69 -16.83 -47.39 -72.20 -108.65 -120.48 -226.41 -301.79 -367.49 -332.92 -361.58 -284.30 -210.90 -106.65 -124.34 -117.97 -100.61 -75.84 -70.72 -60.28 -54.26 -53.20 -66.75 -87.96 -100.16 -112.83 -114.83 -109.89 -113.97 -76.34 -107.01 -109.56 -129.03 -114.14 -30.67 -47.29 -36.18

ROCE %

 91.53 107.86 147.85 216.28 106.74 -36.56 -146.80 -201.03 -227.40 -144.23 -118.16 -69.48 -76.01 -56.16 -35.89 -18.80 -70.59 -115.85 -181.61 -205.16 627.67 1512.29 2436.62 2617.74 2573.65 1696.74 791.30 -164.03 -196.73 -185.35 -157.42 -85.34 -101.75 -85.45 -75.56 -55.18 -294.55 -517.51 -673.56 -627.95 -876.54 -885.76 -942.79 -645.24 -549.57 -205.31 164.45 331.15 95.67 140.75 94.73

Current Ratio

 0.3 0.3 0.3 0.4 0.5 0.6 0.8 1.1 1.3 2.0 4.9 5.5 5.5 5.5 5.5 16.9 16.9 16.9 16.9 4.3 4.3 4.3 4.3 1.4 1.4 1.4 1.4 4.2 4.2 4.2 4.2 19.4 19.4 19.4 19.4 17.4 17.4 17.4 17.4 4.3 4.3 4.3 4.3 5.8 5.8 5.8 5.8 3.0 3.0 3.0 3.0

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD